Navigation Links
A New Technology for Safe Tumor Surgery

3-Tesla MRI in surgical decision-making minimizes the potential for unsuccessful tumor-removal surgeries by providing a new level of capability to predict surgical// outcomes. A Tesla is a unit of magnet strength. A 3-Tesla is one of the strongest commercially available.

In their report, Mayo physicians describe a case study of five patients. The team used an advanced magnetic resonance imaging (MRI) system performed on a 3-Tesla magnet to help identify suitable candidates for a difficult tumor-removal surgery.

Four had neurofibromatosis, a condition with a predisposition to nerve-related tumors. All patients suffered from growths called ‘sciatic notch dumbbell-shaped’ tumors. The tumors were benign, but resulted in neurologic dysfunction and disabling pain.

With the 3-Tesla MRI images, Mayo Clinic surgeons from three specialties -- neurosurgery, colorectal and orthopedic surgery -- obtained sufficiently detailed pictures of the tumor and nerve relationship before surgery in all five cases to accurately predict which patients would benefit from surgery. In three cases the tumor was predicted to be distinct from the main sciatic nerve, and the tumor was safely removed. All three patients experienced relief from pain and had no recurrent growth one year after surgery. In the other two cases, the tumor was predicted to be so entwined in the nerve that surgery would have damaged the nerve. Those patients did not undergo surgery.

‘In the past, if surgeons couldn't tell prior to surgery where the exact location of the large tumor was in relation to the sciatic nerve, it meant they couldn't predict in which cases surgery could be performed safely,’ explains Robert Spinner, M.D., the lead neurosurgeon on the Mayo Clinic team.

A standardized surgical approach for safe and complete removal of sciatic notch dumbbell-shaped tumors has been problematic for at least three reasons.

These tumors are: relatively
'"/>




Page: 1 2

Related medicine news :

1. New Technology In MRI Scan Help Test Brain Cancer Therapy
2. Emergence Of New Gene Scanning Technology In Disease Research
3. Scientists Develop New Technology To Find About Human Ancestors’ Teet
4. Scientists Consider About New Technology Called Nanotechnology
5. Prostate Cancer Can Be Treated By Application Of LASER Technology
6. Georgia Institute of Technology develops doppler Vein finder
7. Novel Technology For Early Detection of Gastrointestinal Cancer
8. Winter Blues Treated by Breakthrough Lighting Technology
9. Bio-Technology Initiatives to Feed Research On Sorghum Crop
10. Technology Can Help Fight Health Care Costs
11. Technology at its nano best: hand-held lab-on-a-chip for blood tests
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Technology for Safe Tumor Surgery

(Date:8/20/2008)... secondary life insurance market ranked 156 among ...merica on Inc. 500 list, BETHESDA, Md., Aug. 20 /...in the secondary life insurance market, announced ...ing insurance related company in the US by,Inc. ma...8 Inc. 500 list of,fastest growing companies in Am...
(Date:8/20/2008)...esidents Gain Access to High Quality Care as State...g. 20 /PRNewswire-USNewswire/ -- Patients who suff...splant will no longer have to,seek that highly spe...p,care outside the borough of the Bronx. Area pati...gh-quality care locally, without having to travel,...
(Date:8/20/2008)...PRINGS, Pa., Aug. 20 /PRNewswire-USNewswire/ -- Go... agricultural industry is struggling,with high fue...ng the need,to secure the state,s energy independe...g adults., Nearly 900 guests gathered to hear the...ay Luncheon at Ag Progress Days, Pennsylvania,s,la...
(Date:8/20/2008)...n of brown globules helps burn calories, hints of ..., Aug. 20 (HealthDay News) -- A protein that induc...good" brown fat that helps burn calories and plays...he Joslin Diabetes Center in Boston. , They sai...ay help lead to new ways to prevent and treat obes...
Breaking Medicine News(10 mins):Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:Liver Transplant Program Established At Montefiore 2Health News:Liver Transplant Program Established At Montefiore 3Health News:Liver Transplant Program Established At Montefiore 4Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Bone Growth Protein Also Promotes 'Good' Fat 2
...alth System have identified, for the first time ev...ry the genes for nicotine// dependence (ND) in an ...ome-wide study of such linkage and included the la...n this type of linkage study. Until this study, pa...
... and dedication, have led their families to far aw...s with their men content to play// house-husband. ...essful man, there is a woman' - to read - 'There i...y of each family' to suit the European Malayalis. ...
...rtly after being admitted to a Jakarta hospital te...'s human toll from the H5N1 virus to 51, health of...uburb in southern Jakarta, died less than an hour ...o Infectious Disease Hospital last week, which is ...
... of medical specialists and provide special allowa... to provide due healthcare to people. "Providing ...priority of the state government and for this the ...es to doctors posted in rural areas. If needed, sp...
Other Medicine News:Health News:Researchers Locate Genetic Link for Nicotine Dependence Among African Americans 2Health News:Malayali Nurses - Lifeline of Keralites Abroad 2Health News:Malayali Nurses - Lifeline of Keralites Abroad 3
(Date:8/14/2008)... development to begin in late 2008 or in early 200...tCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO ) today anno...concept trial of NU172, demonstrating that the dir...ined anticoagulation with a rapid,return toward ba...afety,profile., "NU172 has the potential to addre...
(Date:8/13/2008)... Fat Intake Improves Insulin Sensitivity and Reduc...ine Responsiveness, PHOENIX, Aug. 13 /PRNewswire-...Kronos Longevity Research Institute (KLRI) found t...nsitivity and reduces inflammatory,markers, but do...was,recently published in Hormones and Metabolic R...
(Date:8/13/2008)...CRP with ISIS 353512 could provide therapeutic ben...mmatory diseases, CARLSBAD, Calif., Aug. 13 /PRNe...asdaq: ISIS ) announced today it has initiated a,...at inhibits the,production of C-reactive protein (...ts with a variety of diseases including cardiovasc...
(Date:8/12/2008)...alif., Aug. 12 /- DURECT Co...e US Food and Drug Administration,(FDA) has accept... granted,Priority Review. The FDA typically grants...potential to demonstrate significant improvements,...mpleting review of a drug,with Priority Review sta...
Breaking Medicine Technology:Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Study Shows Benefits of a High Omega-3 Diet in Older Adults 2Study Shows Benefits of a High Omega-3 Diet in Older Adults 3Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 2REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 3Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross 26 Blue Shield Association 14353 1Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross 26 Blue Shield Association 14353 2Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 1Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 2Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 3Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 4Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 5Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 1Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 2Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 3Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 4Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 5Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 6Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 7Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 1Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 2Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 3Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 4Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 5Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 6
...ALEIGH, N.C., April 18, 2007 /PRNewswire/ -- Micel...ll be presenting,data on use of its supercritical ...ug-eluting stents at the upcoming Society for,Biom...Chicago,Illinois. , The abstracts describe use of... e-RESS technology to create drug-eluting stents,c...
...ta Reported at American Association for Cancer Res...RNewswire-FirstCall/ -- Favrille,Inc. , a biophar...tive immunotherapies for the treatment of cancer, ...d activity from insect-cell,derived idiotype (Id) ...immunotherapy product candidate FavId(R) for B-cel...
Other Medicine Technology:Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 2Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 4
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: